Olanzapine

General Information

Olanzapine Impurities and Olanzapine

Daicel Pharma offers Olanzapine impurities such as N-Demethyl Olanzapine, Olanzapine BP Impurity-3, Olanzapine degradation impurities 1 and 2, Olanzapine Related Compound A, Olanzapine Related Compound B, and Olanzapine Thiolactam Impurity. These impurities are critical for determining the quality, stability, and safety of Olanzapine, an active pharmaceutical component. Daicel Pharma custom synthesizes and distributes Olanzapine impurities globally.

Olanzapine [CAS: 132539-06-1] is a thienobenzodiazepine derivative. It functions as a histamine antagonist, muscarinic antagonist, serotonin antagonist, dopaminergic antagonist, antiemetic, second-generation antipsychotic, and serotonin uptake inhibitor. It contains benzodiazepines, N-methylpiperazines, and N-arylpiperazines.

Olanzapine: Use and Commercial Availability  

Olanzapine’s use orally and intramuscularly treats persistent schizophrenia and other mental diseases, such as bipolar disorder, including mixed or manic episodes in patients. Olanzapine also has approval for the short-term treatment of acute manic or mixed episodes associated with bipolar I disorder in adults when combined with lithium or valproate. Olanzapine treats moderate to severe manic episodes. Olanzapine prevents recurrence in patients with bipolar disorder whose manic episode has responded to Olanzapine therapy. Olanzapine is available as Zyprexa, Zyprexa Zydis, and Zyprexa Relprevv.

Olanzapine Structure and Mechanism of Action

The chemical name of Olanzapine is 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine. Its chemical formula is C₁₇H₂₀N₄S, and its molecular weight is approximately 312.4 g/mol.

The mechanism of action of Olanzapine is unknown concerning other drugs.

Olanzapine Impurities and Synthesis

Olanzapine impurities are unwanted substances that can be present in the drug formulation of Olanzapine. They can arise during synthesis¹, storage, or degradation processes. Controlling impurities is essential for maintaining the quality and effectiveness of Olanzapine.

Daicel provides a Certificate of Analysis (CoA) of Olanzapine impurities such as N-Demethyl Olanzapine, Olanzapine BP Impurity-3, Olanzapine degradation impurities 1 and 2, Olanzapine Related Compound A, Olanzapine Related Compound B, and Olanzapine Thiolactam Impurity. Our cGMP-compliant analytical laboratory offers the CoA, which contains extensive characterization data such as 1H NMR, 13C NMR, IR, MASS, and HPLC purity². We give additional characterization data, such as 13C-DEPT, on request. Fortunately, Daicel Pharma has a team of specialists to offer Olanzapine unknown impurities. Our professionals provide exceptionally pure Olanzapine-D3, deuterium-labeled standards of Olanzapine that are essential for bioanalytical research and Bioavailability/Bioequivalence (BA/BE) studies.